Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test
(Alliance News) - Ixico PLC on Tuesday hailed regulatory approval for a new Alzheimer's test, which it was contracted to analyse during clinical trials. Read More
Price | 9.75p on 04-07-2025 | at 18:20:07
---|---|
Change | -0.40p -3.94% |
Buy | 10.00p |
Sell | 9.50p |
Buy / Sell IXI Shares |
Last Trade: | Buy 5,005.00 at 9.99p |
Day's Volume: | 55,900 |
Last Close: | 9.75p |
Open: | 10.15p |
ISIN: | GB00BFXR4C20 |
Day's Range | 9.75p - 10.15p |
52wk Range: | 6.60p - 13.50p |
Market Capitalisation: | £9m |
VWAP: | 9.835106p |
Shares in Issue: | 93m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 5,005 | 9.99p | Ordinary |
14:32:18 - 04-Jul-25 |
Sell* | 17,895 | 9.50p | Ordinary |
14:14:28 - 04-Jul-25 |
Buy* | 29,000 | 10.00p | Ordinary |
12:22:50 - 04-Jul-25 |
Buy* | 4,000 | 9.945p | Ordinary |
12:05:58 - 04-Jul-25 |
Buy* | 100 | 10.30p | SI Trade |
15:17:12 - 03-Jul-25 |
Buy* | 200 | 10.30p | SI Trade |
15:17:12 - 03-Jul-25 |
Sell* | 8 | 10.00p | SI Trade |
15:17:12 - 03-Jul-25 |
Buy* | 25 | 10.30p | SI Trade |
15:17:12 - 03-Jul-25 |
Buy* | 200 | 10.30p | SI Trade |
15:17:12 - 03-Jul-25 |
Buy* | 194 | 10.30p | SI Trade |
15:17:12 - 03-Jul-25 |
Ixico (IXI) Regulatory News |
||
Date | Source | Headline |
---|---|---|
13th Jun 2025 8:03 am | RNS | Share option awards and PDMR Dealing |
10th Jun 2025 7:00 am | RNS | FDA Clearance of Alzheimer's Diagnostic Biomarker |
20th May 2025 6:00 pm | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | Half-year Report |
8th May 2025 11:30 am | RNS | Holding(s) in Company |
6th May 2025 7:00 am | RNS | Notice of Interim Results & Investor Presentation |
16th Apr 2025 7:00 am | RNS | Trading Update |
27th Feb 2025 7:00 am | RNS | Contract Win |
12th Feb 2025 7:00 am | RNS | Further Validation of IXICO’s AI Imaging Platform |
7th Feb 2025 3:00 pm | RNS | Issue of share options and PDMR dealing |